ProLung, Inc. Appoints Mark Anderson, CPA as Chief Financial Officer
ProLung, Inc. ("ProLung" or the "Company") is focused on making a difference in time for lung cancer patients with its innovative predictive analytics technology and non-invasive tests for the risk stratification of indeterminate pulmonary nodules. Today ProLung announces the appointment of Mark V. Anderson, CPA as Chief Financial Officer.
View full press release